中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2011年
17期
2315-2316
,共2页
米志奎%余寿杰%苏加武%方康晓
米誌奎%餘壽傑%囌加武%方康曉
미지규%여수걸%소가무%방강효
结核,肺%分枝杆菌,结核%痰%培养技术%微生物敏感性试验
結覈,肺%分枝桿菌,結覈%痰%培養技術%微生物敏感性試驗
결핵,폐%분지간균,결핵%담%배양기술%미생물민감성시험
Tuberculosis,pulmonary%Mycobacterium tuberculosis%Sputum%Culture techniques%Microbial sensitivity tests
目的 分析影响结核分枝杆菌痰培养及耐利福平药敏试验的结果及相关因素。方法 对227例痰涂片阳性患者进行痰培养及耐利福平的药敏试验。结果 227例中痰培养阳性220例(96.9%),涂阳培阴2例(0.9%),污染5例(2.2%)。耐利福平药敏试验中,新患者耐药比率为10.4%,初治失败者为37.5%,复治者为28.9%。结论 结核分枝杆菌在培养、药敏过程中要严格按照操作步骤进行,初治失败患者和复治患者耐利福平比率远高于新患者。
目的 分析影響結覈分枝桿菌痰培養及耐利福平藥敏試驗的結果及相關因素。方法 對227例痰塗片暘性患者進行痰培養及耐利福平的藥敏試驗。結果 227例中痰培養暘性220例(96.9%),塗暘培陰2例(0.9%),汙染5例(2.2%)。耐利福平藥敏試驗中,新患者耐藥比率為10.4%,初治失敗者為37.5%,複治者為28.9%。結論 結覈分枝桿菌在培養、藥敏過程中要嚴格按照操作步驟進行,初治失敗患者和複治患者耐利福平比率遠高于新患者。
목적 분석영향결핵분지간균담배양급내리복평약민시험적결과급상관인소。방법 대227례담도편양성환자진행담배양급내리복평적약민시험。결과 227례중담배양양성220례(96.9%),도양배음2례(0.9%),오염5례(2.2%)。내리복평약민시험중,신환자내약비솔위10.4%,초치실패자위37.5%,복치자위28.9%。결론 결핵분지간균재배양、약민과정중요엄격안조조작보취진행,초치실패환자화복치환자내리복평비솔원고우신환자。
Objective To analyze influence mycobacterium tuberculosis sputum culture and heat-proof rifabutin antimicrobial susceptibility test results and related factors.Methods To the centers for disease control and prevention of Huainan tuberculosis clinic into the program to treat 227 sputum smear-positive patients in the sputum culture and heat-proof rifabutin of antimicrobial susceptibility test. Results Among 227 patients sputum culture positive 220 cases, accounting for 96. 9%, sputum culture-negative 2 cases, accounting for 0. 9%, pollution, 5 cases of 2. 2%. Resistance rifabutin antimicrobial susceptibility test,a new patient resistance ratio for 10. 4% ,early cure loser for 37.5%, concomitant person for 28.9%. Conclusion The mycobacterium tuberculosis in the process of cultivation should be strictly according to the requirements of collecting, processing, specimen vaccination, preservation and observation. Early cure failure patients and treat patients resistant rifabutin rate was far higher than new patients, the patients with irregular or unreasonable chemotherapy were concerned.